Mucosal immune response in biology, disease prevention and treatment

被引:13
作者
Zhou, Xiaoxue [1 ,2 ,3 ]
Wu, Yuchen [4 ]
Zhu, Zhipeng [2 ,3 ]
Lu, Chu [5 ]
Zhang, Chunwu [4 ]
Zeng, Linghui [1 ]
Xie, Feng [5 ]
Zhang, Long [2 ,3 ,6 ,7 ]
Zhou, Fangfang [5 ]
机构
[1] Hangzhou City Univ, Sch Med, Hangzhou, Peoples R China
[2] Zhejiang Univ, Life Sci Inst, MOE Lab Biosyst Homeostasis & Protect, Hangzhou, Peoples R China
[3] Zhejiang Univ, Life Sci Inst, Innovat Ctr Cell Signaling Network, Hangzhou, Peoples R China
[4] Wenzhou Med Univ, Sch Med 1, Wenzhou, Zhejiang, Peoples R China
[5] Soochow Univ, Affiliated Hosp 1, Inst Biol & Med Sci, Suzhou Med Coll, Suzhou, Jiangsu, Peoples R China
[6] Nanchang Univ, Affiliated Hosp 1, Jiangxi Med Coll, MOE Basic Res & Innovat Ctr Targeted Therapeut Sol, Nanchang, Peoples R China
[7] Zhejiang Univ, Canc Ctr, Hangzhou, Zhejiang, Peoples R China
基金
国家重点研发计划;
关键词
INNATE LYMPHOID-CELLS; PLASMACYTOID DENDRITIC CELLS; INTESTINAL M-CELLS; FC-ALPHA-RI; NF-KAPPA-B; T-CELLS; HELICOBACTER-PYLORI; GUT MICROBIOTA; NONNEUTRALIZING ANTIBODIES; TRANSEPITHELIAL TRANSPORT;
D O I
10.1038/s41392-024-02043-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mucosal immune system, as the most extensive peripheral immune network, serves as the frontline defense against a myriad of microbial and dietary antigens. It is crucial in preventing pathogen invasion and establishing immune tolerance. A comprehensive understanding of mucosal immunity is essential for developing treatments that can effectively target diseases at their entry points, thereby minimizing the overall impact on the body. Despite its importance, our knowledge of mucosal immunity remains incomplete, necessitating further research. The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has underscored the critical role of mucosal immunity in disease prevention and treatment. This systematic review focuses on the dynamic interactions between mucosa-associated lymphoid structures and related diseases. We delve into the basic structures and functions of these lymphoid tissues during disease processes and explore the intricate regulatory networks and mechanisms involved. Additionally, we summarize novel therapies and clinical research advances in the prevention of mucosal immunity-related diseases. The review also addresses the challenges in developing mucosal vaccines, which aim to induce specific immune responses while maintaining tolerance to non-pathogenic microbes. Innovative therapies, such as nanoparticle vaccines and inhalable antibodies, show promise in enhancing mucosal immunity and offer potential for improved disease prevention and treatment.
引用
收藏
页数:32
相关论文
共 549 条
[1]   The Prevalence and Risk Factors for Pneumococcal Colonization of the Nasopharynx among Children in Kilifi District, Kenya [J].
Abdullahi, Osman ;
Karani, Angela ;
Tigoi, Caroline C. ;
Mugo, Daisy ;
Kungu, Stella ;
Wanjiru, Eva ;
Jomo, Jane ;
Musyimi, Robert ;
Lipsitch, Marc ;
Scott, J. Anthony G. .
PLOS ONE, 2012, 7 (02)
[2]   Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever [J].
Abreu-Mota, Tiago ;
Hagen, Katie R. ;
Cooper, Kurt ;
Jahrling, Peter B. ;
Tan, Gene ;
Wirblich, Christoph ;
Johnson, Reed F. ;
Schnell, Matthias J. .
NATURE COMMUNICATIONS, 2018, 9
[3]   Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2 [J].
Afkhami, Sam ;
D'Agostino, Michael R. ;
Zhang, Ali ;
Stacey, Hannah D. ;
Marzok, Art ;
Kang, Alisha ;
Singh, Ramandeep ;
Bavananthasivam, Jegarubee ;
Ye, Gluke ;
Luo, Xiangqian ;
Wang, Fuan ;
Ang, Jann C. ;
Zganiacz, Anna ;
Sankar, Uma ;
Kazhdan, Natallia ;
Koenig, Joshua F. E. ;
Phelps, Allyssa ;
Gameiro, Steven F. ;
Tang, Shangguo ;
Jordana, Manel ;
Wan, Yonghong ;
Mossman, Karen L. ;
Jeyanathan, Mangalakumari ;
Gillgrass, Amy ;
Medina, Maria Fe C. ;
Smaill, Fiona ;
Lichty, Brian D. ;
Miller, Matthew S. ;
Xing, Zhou .
CELL, 2022, 185 (05) :896-+
[4]   Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19 [J].
Ahn, Ji Hoon ;
Kim, JungMo ;
Hong, Seon Pyo ;
Choi, Sung Yong ;
Yang, Myung Jin ;
Ju, Young Seok ;
Kim, Young Tae ;
Kim, Ho Min ;
Rahman, Md Tazikur ;
Chung, Man Ki ;
Hong, Sang Duk ;
Bae, Hosung ;
Lee, Chang-Seop ;
Koh, Gou Young .
JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (13)
[5]   Recognition of pathogen-associated molecular patterns by TLR family [J].
Akira, S ;
Hemmi, H .
IMMUNOLOGY LETTERS, 2003, 85 (02) :85-95
[6]   B cell memory: building two walls of protection against pathogens [J].
Akkaya, Munir ;
Kwak, Kihyuck ;
Pierce, Susan K. .
NATURE REVIEWS IMMUNOLOGY, 2020, 20 (04) :229-238
[7]   Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection [J].
Alexandrova, Yulia ;
Costiniuk, Cecilia T. ;
Jenabian, Mohammad-Ali .
FRONTIERS IN IMMUNOLOGY, 2022, 12
[8]   Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins [J].
Ali, Youssif M. ;
Ferrari, Matteo ;
Lynch, Nicholas J. ;
Yaseen, Sadam ;
Dudler, Thomas ;
Gragerov, Sasha ;
Demopulos, Gregory ;
Heeney, Jonathan L. ;
Schwaeble, Wilhelm J. .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[9]   Considerations for Novel COVID-19 Mucosal Vaccine Development [J].
Alturaiki, Wael .
VACCINES, 2022, 10 (08)
[10]  
AMERONGEN HM, 1991, J ACQ IMMUN DEF SYND, V4, P760